Amgen
Amphivena Therapeutics
AstraZeneca
Eli Lilly
GlaxoSmithKline
Innovent
Janssen Pharmaceuticals
Jasper Therapeutics
Pfizer
Roche
Published | Pages | Publisher | Report code |
---|---|---|---|
May 2022 | 330 | Kuick Research | ASDR-601257 |
Amgen
Amphivena Therapeutics
AstraZeneca
Eli Lilly
GlaxoSmithKline
Innovent
Janssen Pharmaceuticals
Jasper Therapeutics
Pfizer
Roche